Pinnacle Associates’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.89M Sell
208,527
-61,908
-23% -$2.05M 0.1% 196
2025
Q1
$10.9M Sell
270,435
-15,097
-5% -$607K 0.16% 143
2024
Q4
$13.4M Buy
285,532
+27,174
+11% +$1.28M 0.18% 117
2024
Q3
$21.6M Buy
258,358
+4,494
+2% +$375K 0.37% 72
2024
Q2
$13.8M Sell
253,864
-3,303
-1% -$179K 0.22% 114
2024
Q1
$18M Sell
257,167
-1,191
-0.5% -$83.5K 0.28% 93
2023
Q4
$21.6M Sell
258,358
-971
-0.4% -$81.1K 0.36% 73
2023
Q3
$7.64M Sell
259,329
-11,032
-4% -$325K 0.14% 175
2023
Q2
$8.82M Sell
270,361
-9,645
-3% -$315K 0.15% 162
2023
Q1
$9.85M Sell
280,006
-4,739
-2% -$167K 0.2% 135
2022
Q4
$13M Sell
284,745
-5,106
-2% -$234K 0.28% 100
2022
Q3
$14M Sell
289,851
-10,295
-3% -$499K 0.32% 92
2022
Q2
$11.8M Sell
300,146
-1,318
-0.4% -$51.8K 0.26% 118
2022
Q1
$11.1M Sell
301,464
-13,728
-4% -$505K 0.2% 140
2021
Q4
$14.4M Sell
315,192
-2,023
-0.6% -$92.2K 0.25% 121
2021
Q3
$11.3M Sell
317,215
-12,180
-4% -$435K 0.21% 130
2021
Q2
$6.52M Buy
329,395
+5,096
+2% +$101K 0.12% 184
2021
Q1
$7.54M Sell
324,299
-35,425
-10% -$824K 0.14% 160
2020
Q4
$7.48M Sell
359,724
-24,337
-6% -$506K 0.15% 152
2020
Q3
$8.32M Sell
384,061
-15,117
-4% -$327K 0.2% 132
2020
Q2
$9.41M Sell
399,178
-3,715
-0.9% -$87.6K 0.23% 116
2020
Q1
$4.75M Sell
402,893
-71,583
-15% -$844K 0.14% 160
2019
Q4
$5.03M Sell
474,476
-45,095
-9% -$478K 0.11% 201
2019
Q3
$5.91M Sell
519,571
-27,075
-5% -$308K 0.14% 179
2019
Q2
$6.15M Sell
546,646
-53,742
-9% -$605K 0.14% 177
2019
Q1
$4.86M Buy
600,388
+7,610
+1% +$61.6K 0.11% 201
2018
Q4
$3.75M Sell
592,778
-56,513
-9% -$357K 0.1% 224
2018
Q3
$6.4M Sell
649,291
-109,034
-14% -$1.07M 0.13% 180
2018
Q2
$6.29M Sell
758,325
-130,090
-15% -$1.08M 0.13% 186
2018
Q1
$6.4M Buy
888,415
+10,840
+1% +$78.1K 0.13% 184
2017
Q4
$7.15M Sell
877,575
-131,230
-13% -$1.07M 0.14% 174
2017
Q3
$14.6M Buy
+1,008,805
New +$14.6M 0.27% 98